Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance - PubMed (original) (raw)

Review

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance

M J Gale Jr et al. Clin Diagn Virol. 1998.

Abstract

Background: Chronic infection with hepatitis C virus (HCV) is associated with progressive liver damage, including the development of cirrhosis and hepatocellular carcinoma, and HCV is a leading cause of liver dysfunction worldwide. The current therapy for chronic HCV infection, interferon-alpha (IFN), is effective in a minority of HCV-infected patients. Several studies have demonstrated a correlation between therapeutic outcome and the amino acid sequence of a small region of the HCV non-structural 5A (NS5A) gene product. It has been suggested that this region, termed the interferon sensitivity-determining region (ISDR), may mediate IFN resistance by directly interacting with one or more cellular proteins associated with the IFN-mediated antiviral response.

Objectives: In an attempt to define the molecular mechanism by which the NS5A protein and the ISDR might contribute to HCV resistance to IFN, we examined whether NS5A could regulate the IFN-induced protein kinase, PKR, a primary mediator of the IFN-induced antiviral response.

Study design: Multiple approaches, including in vitro assays using recombinant proteins, the transfection of recombinant clones into cultured cells, and in vivo studies in yeast, were used to examine the interaction of NS5A with PKR, as well as the functional significance of the interaction. An ISDR deletion mutant was prepared to evaluate the importance of the ISDR in mediating the NS5A-PKR interaction and the requirement of this region for PKR inhibition.

Results: NS5A repressed PKR activity through a direct interaction with the protein kinase catalytic domain. Both PKR repression and interaction required the presence of the ISDR.

Conclusions: Inactivation of PKR may be one mechanism by which HCV avoids the antiviral effects of IFN. Thus,therapeutic strategies designed to block the NS5A-PKR interaction may increase the efficacy of IFN therapy in HCV-infected individuals.

PubMed Disclaimer

Cited by

Viral evasion of the integrated stress response through antagonism of eIF2-P binding to eIF2B.
Schoof M, Wang L, Cogan JZ, Lawrence RE, Boone M, Wuerth JD, Frost A, Walter P. Schoof M, et al. Nat Commun. 2021 Dec 7;12(1):7103. doi: 10.1038/s41467-021-26164-4. Nat Commun. 2021. PMID: 34876554 Free PMC article.
Emerging translation strategies during virus-host interaction.
Hoang HD, Neault S, Pelin A, Alain T. Hoang HD, et al. Wiley Interdiscip Rev RNA. 2021 Jan;12(1):e1619. doi: 10.1002/wrna.1619. Epub 2020 Aug 5. Wiley Interdiscip Rev RNA. 2021. PMID: 32757266 Free PMC article. Review.
Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.
Wan Q, Song D, Li H, He ML. Wan Q, et al. Signal Transduct Target Ther. 2020 Jul 13;5(1):125. doi: 10.1038/s41392-020-00233-4. Signal Transduct Target Ther. 2020. PMID: 32661235 Free PMC article. Review.
Strategies to Circumvent Host Innate Immune Response by Hepatitis C Virus.
Patra T, Ray RB, Ray R. Patra T, et al. Cells. 2019 Mar 22;8(3):274. doi: 10.3390/cells8030274. Cells. 2019. PMID: 30909456 Free PMC article. Review.
dsRNA Binding Domain of PKR Is Proteolytically Released by Enterovirus A71 to Facilitate Viral Replication.
Chang YH, Lau KS, Kuo RL, Horng JT. Chang YH, et al. Front Cell Infect Microbiol. 2017 Jun 28;7:284. doi: 10.3389/fcimb.2017.00284. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28702377 Free PMC article.

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance - PubMed (original) (raw)